real-time news and commentary for investors
Tuesday, Sep 24
EnteroMedics says obesity treatment on track for approval in 2014
- EnteroMedics (ETRM) receives a standard formal response from the FDA regarding the PMA for the Maestro Rechargeable System.
- CEO Mark Knudson is "encouraged by the [regulator's] responsiveness" and says the company "continues on track for a panel in late Q4 2013/Q1 2014 with approval decision in H1 2014." (PR)
- ETRM +3% premarket.